They also grew tiny 3D mini-tumors from patients duodenal, ileal, and pancreatic NETs and exposed them to semaglutide, a commonly used GLP-1 drug, to see how the cells responded What did they find
New Update: We are also launching prescription Wegovy pills , expanding options for patients who prefer oral treatment
Xichen Lin, PhD, Chief Scientific Officer
M., Adzhigirey, M., Day, T., Annabhimoju, R
Fieldhouse writes that it preferentially targets the production of cyclic adenosine monophosphate and notes that, in a recent clinical trial, 92.8% of the participants lost at least 5% of their body weight
The opportunity The data points to a major expansion opportunity for oral GLP-1s in the UK market, particularly among younger adults and treatment-hesitant patients